Dr. Jamie Y Hur, D.O.
Claim this profileMore about Jamie Y Hur, D.O.
Clinical Trial Related
1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Jamie Y Hur, D.O. has experience with
- Fostamatinib
Breakdown of trials Jamie Y Hur, D.O. has run
Bronchiolitis Obliterans Syndrome
Thrombocytopenic Purpura
Acute Graft-versus-Host Disease
Autoimmune Hemolytic Anemia
Graft-versus-Host Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jamie Y Hur, D.O. specialize in?
Jamie Y Hur, D.O. focuses on Bronchiolitis Obliterans Syndrome and Thrombocytopenic Purpura. In particular, much of their work with Bronchiolitis Obliterans Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Jamie Y Hur, D.O. currently recruiting for clinical trials?
No, Jamie Y Hur, D.O. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jamie Y Hur, D.O. has studied deeply?
Yes, Jamie Y Hur, D.O. has studied treatments such as Fostamatinib.
What is the best way to schedule an appointment with Jamie Y Hur, D.O.?
Apply for one of the trials that Jamie Y Hur, D.O. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.